TG
MYGN icon

TCW Group’s Myriad Genetics MYGN Stock Holding History

TCW Group’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-16,200
Closed -$333K – 691
2016
Q3 		$333K Sell
16,200
-4,500
-22% -$114K ﹤0.01% 633
2016
Q2 		$633K Hold
20,700
– – ﹤0.01% 584
2016
Q1 		$775K Hold
20,700
– – 0.01% 549
2015
Q4 		$893K Sell
20,700
-887
-4% -$37.5K 0.01% 527
2015
Q3 		$809K Buy
+21,587
New +$766K 0.01% 560

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

TCW Group's MYGN Position: Q4 2016 in Review

TCW Group sold out of Myriad Genetics (MYGN) in Q4 2016, closing a stake of 16,200 shares — an estimated $333K sold.

TCW Group first reported a position in MYGN in Q3 2015 and held it in 5 quarters. The position peaked at $893K in Q4 2015. 223 funds tracked by Wall St. Rank hold MYGN as of Q4 2016.

  • TCW Group reported no remaining Myriad Genetics position as of Q4 2016 after selling out during the quarter.
  • TCW Group sold 16,200 Myriad Genetics shares in Q4 2016, an estimated $333K.
  • TCW Group first reported a position in Myriad Genetics in Q3 2015 and held it in 5 quarters.
  • TCW Group's Myriad Genetics position peaked at $893K in Q4 2015.
  • 223 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2016.

Based on TCW Group's 13F filing for Q4 2016, filed 10 Feb 2017.